Chris Childs, Managing Director and Head of Repository & Derivatives Services at DTCC, discusses the top considerations for reporting rule rewrites for OTC derivatives in APAC.
The rewrites adopt the UTI (unique trade identifiers), UPI (unique product identifiers) and CDE (critical data elements). Childs offers recommendations on how in-scope firms can prepare.
00:09 – What is the current OTC trade reporting landscape in APAC?
00:43 – What are the top three challenges that in-scope firms WIll face with the upcoming trade reporting rules rewrites in Asia Pacific?
01:44 – What is your advice for in-scope firms?